Category: Vaccine Waning
Pfizer CEO fighting his second Covid infection in 5 weeks
Pfizer CEO and Chairman Albert Bourla: “I have tested positive for COVID.”… ...More...
Lancet: Natural immunity associated with a 95% lower risk of SARS-CoV-2 infection
After the first 3 months, natural immunity was associated with a 95% lower risk of SARS-CoV-2 infection and an 87% lower risk of COVID-19 hospitalisation for up to 20 months.… ...More...
Russia: Eight times vaccinated Vladimir Zhirinovsky dies of Covid-19
Vladimir Zhirinovsky said that in a year and a half he had shot himself eight times with different Covid-19 vaccines.… ...More...
Preprint: Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials
“The excess risk of serious adverse events of special interest surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group in both Pfizer and Moderna trials.”… ...More...
Preprint: The efficacy of facemasks in the prevention of Covid-19
The probability of getting COVID-19 for mask wearers was just 7%, whereas the probability of getting COVID-19 for non-mask wearers was 52%.… ...More...
UK: Pandemic record Covid infection rates in Scotland, Wales and Northern Ireland
Data from the ZOE Covid-19 app today shows that there are pandemic record Covid incidence rates in Scotland, Wales and Northern Ireland.… ...More...
Preprint: Vaccine effectiveness for the third dose in negative since December 2021
“There is no discernable vaccine effectiveness among ≥18 years of age, vaccinated third dose population since the beginning of the Omicron variant surge.”… ...More...
Jenny Harris: Quite likely BA.5 hospitalizations will exceed those of BA.2
Dr Jenny Harris, of the UKHSA, has said in an interview today that it is quite likely that BA.5 hospitalizations will “peak over” those of the Omicron BA.2 wave, meaning that Britain could see the highest hospitalization figures for eighteen months.… ...More...
Covid-19: Where’s the herd immunity?
“Contrary to the myth that we are sliding into a comfortable evolutionary relationship with a common-cold-like, friendly virus, this is more like being trapped on a rollercoaster in a horror film.”… ...More...
WHO: BA.5 now dominant globally
As of epidemiological week 24, BA.5 represents 43% of global sequences at Gisaid, BA.2 represents 25%, BA.4 represents 12%, and BA.2.12.1 represents 11%.… ...More...
Preprint: BA.2.12.1, BA.4, and BA.5 substantially escape neutralizing antibodies
These data show that the BA.2.12.1, BA.4, and BA.5 subvariants substantially escape neutralizing antibodies induced by both vaccination and infection.… ...More...
France: BA.5 at 41% of sequences in week 24, 2022
“Progressive replacement of BA.2 by BA.5 with a strong increase in detection (41%), increased presence of the mutation at position L452 in screening (64% in week 24 vs 47% in week 23), linked to the increase of certain Omicron sub-lineages including BA.4 and BA.5.”… ...More...
UK ONS: Large increase in re-infections since Omicron
ONS: “There has been a large increase in the rates for all re-infections and re-infections with a high viral load since the Omicron variants became most common.”… ...More...
Denmark: Risk assessment for SARS-CoV-2 Omicron subvariants BA.5, BA.2.12.1 and BA.4
The sub-variants provisionally amount to 21% (BA.5) and 12.4% (BA.2.12.1) per June 8 2022.… ...More...